(Q57911906)

English

Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

multiple sclerosis

0 references

Massimo Filippi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Carla Tortorella

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Federica Agosta

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

C Avolio

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

M Ruggieri

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

V Tomassini

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

C Pozzilli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

S Stecchi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

P Giaquinto

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

441-446

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Metalloproteinases in biology and pathology of the nervous system.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Tissue inhibitors of metalloproteinases: evolution, structure and function

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Correlation between enhancing lesion number and volume on standard and triple dose gadolinium-enhanced brain MRI scans from patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Interferon beta treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1193OA

21 January 2018

Identifiers

10.1191/1352458505MS1193OA

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16042227%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57911906&oldid=1998204474"